Vigonvita Life Sciences

This was a first-in-human study to check the safety and see how the body processes a new drug called LV232. It involved 81 healthy Chinese volunteers who received a single dose of either the drug or a placebo. The main goal was to see how safe the drug is and to measure its level…

This early-stage study aimed to understand the safety and how the body processes a new capsule called LV232. It involved 49 healthy volunteers to test different doses and see if eating food changes how the capsule is absorbed. The main goal was to gather basic safety and absorpti…

This study aimed to understand how two different versions of an oral antiviral suspension are absorbed by the body. It involved 18 healthy Chinese adults who each took both versions in a specific order, with a break in between. The main goal was to measure and compare drug levels…